VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (6291)	1/15/1999 9:15:00 PM
From: Biomaven	Read Replies (1) of 9719

Rman, Well AIMM is trading at around cash, and they comfortably have enough to finish their big Phase III RA trial. So having satisfied the bean-counter requirements, the only remaining question is whether their stuff is going to work or not. <G> I met their head honcho socially several years ago (before their trial went bust) and he pretty much convinced me that they were dealing with a real phenomenon. My hunch is that at best it'll end up working only for some subset of their subjects though, and this won't be enough either to satisfy the FDA or for the company to live long and prosper. I haven't looked at it for a few years though, so I'm not real up to date on what they've been doing. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next